Asian Americans have better outcomes of non-metastatic gastric cancer compared to other United States racial groups: A secondary analysis from a randomized study

Table 1 Baseline characteristics of patients included in the current analysis, 546 patients

Parameter	n (%)
Age
< 60 yr	294 (53.8)
≥ 60 yr	252 (46.2)
Sex
Male	371 (67.9)
Female	175 (32.1)
Race
White	403 (73.8)
Black	70 (12.8)
Asian	45 (8.2)
Others	28 (5.1)
Ethnicity
Hispanic	54 (9.9)
Non-Hispanic	445 (81.5)
Unknown	47 (8.6)
Performance status
0	276 (50.5)
1	257 (47.1)
2	13 (2.4)
History of prior cancer
Yes	22 (4)
No	516 (94.5)
Unknown	8 (1.5)
T stage
T1	33 (6)
T2	219 (40.1)
T3	259 (47.4)
T4	23 (4.2)
Unknown	12 (2.2)
N stage
N0	77 (14.1)
N1	312 (57.1)
N2	105 (19.2)
N3	34 (6.2)
Unknown	18 (3.3)
Lymph node ratio (mean; SD)	0.32; 0.307
Histologic grade
Grade 1	15 (2.7)
Grade 2	139 (25.5)
Grade 3	360 (65.9)
Grade 4	17 (3.1)
Unknown	15 (2.8)
Primary tumor site
GEJ/ cardia/ fundus	208 (38.1)
Body/antrum/ pylorus	161 (29.5)
Others, NOS	177 (32.4)
Treatment arm
5FU/LCV + RT	280 (51.3)
ECF + RT	266 (48.7)
Completion Of treatment
Completed as planned	359 (65.8)
Stopped because of adverse events	64 (11.7)
Stopped because of progression/death	33 (6)
Stopped because of other reasons (e.g., consent withdrawal)	90 (16.5)

RT: Radiation therapy; NOS: Not otherwise specified; SD: Standard deviation; GEJ: Gastroesophageal junction.